Standout Papers
- Bariatric Surgery (2004)
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults (2013)
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults (2013)
- Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis (2009)
- Fat tissue, aging, and cellular senescence (2010)
- Role of Nonexercise Activity Thermogenesis in Resistance to Fat Gain in Humans (1999)
- Splanchnic lipolysis in human obesity (2004)
- JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age (2015)
- Leptin Acts on Human Marrow Stromal Cells to Enhance Differentiation to Osteoblasts and to Inhibit Differentiation to Adipocytes1 (1999)
- Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study (2006)
- Influence of body fat distribution on free fatty acid metabolism in obesity. (1989)
- The Science of Obesity Management: An Endocrine Society Scientific Statement (2018)
- Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia (2013)
- Interindividual Variation in Posture Allocation: Possible Role in Human Obesity (2005)
- Role of Body Fat Distribution and the Metabolic Complications of Obesity (2008)
- Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality (2009)
- Mechanisms and Metabolic Implications of Regional Differences among Fat Depots (2013)
- Targeting senescent cells enhances adipogenesis and metabolic function in old age (2015)
- Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets (2022)
- Metabolic changes in aging humans: current evidence and therapeutic strategies (2022)
Immediate Impact
1 by Nobel laureates 9 from Science/Nature 145 standout
Citing Papers
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
2025 Standout
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
2024 Standout
Works of Michael D. Jensen being referenced
Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial
2024
Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets
2022 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael D. Jensen | 18873 | 2915 | 7869 | 10218 | 322 | 36.6k | |
| Samuel Klein | 22926 | 4585 | 9938 | 6374 | 380 | 46.9k | |
| Lars Sjöström | 12201 | 1461 | 7705 | 8652 | 237 | 27.7k | |
| Matti Uusitupa | 11559 | 1074 | 13017 | 5123 | 477 | 36.3k | |
| Jean‐Pierre Després | 13786 | 1409 | 11152 | 6259 | 387 | 38.3k | |
| Per Björntorp | 14156 | 3276 | 10022 | 2743 | 449 | 31.8k | |
| Steven E. Kahn | 13019 | 2214 | 20367 | 12627 | 467 | 45.2k | |
| K. G. M. M. Alberti | 9506 | 1074 | 16910 | 5729 | 441 | 37.2k | |
| David E. Kelley | 16700 | 4597 | 5830 | 4204 | 197 | 27.8k | |
| Arya M. Sharma | 7337 | 564 | 6189 | 6654 | 405 | 26.1k | |
| Éric Ravussin | 31839 | 5508 | 6675 | 3509 | 550 | 52.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...